DS-3201b in Participants With Lymphomas

Clinical trial NCT02732275 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02732275
Sponsor: Daiichi Sankyo Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Malignant Non-hodgkin Lymphoma

Start date: 2016-03-31
Primary completion: 2022-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.